OFFICIAL PUBLICATION OF

by its subsidiary APPco

Posts in tag

Jurnista

News Pharmacy Announcements

TGA issues product defect correction

Sheshtyn Paola 13/02/2019

Pharmacists are advised that Janssen is undertaking a product defect correction for one batch of Jurnista (hydromorphone hydrochloride) prolonged-release blister packs Janssen, following consultation with the TGA, is undertaking a product defect …

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Jurnista

TGA issues product defect correction

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

TGA issues product defect correction

MENU

Hi there! 👋 Looks like you’re not logged in.